APO RESEARCH · REPORT
Diabetic Gastroparesis Treatment
Diabetic gastroparesis refers to cases of the digestive condition gastroparesis that diabetes causes.
Product & engineering
Understand the product.
Diabetic gastroparesis refers to cases of the digestive condition gastroparesis that diabetes causes.
During normal digestion, the stomach contracts to help break down food and move it into the small intestine. Gastroparesis disrupts the stomach’s contraction, which can interrupt digestion. Diabetes can cause gastroparesis due to its effects on the nervous system.
Both type 1 diabetes and type 2 diabetes can cause nerve damage. One of the nerves diabetes may damage is the vagus nerve. The vagus nerve controls the movement of food through the stomach. When the vagus nerve experiences damage, the muscles in the stomach and other parts of the digestive tract are not able to function properly. When this happens, food cannot move as quickly through the digestive system. Gastroparesis is also known as delayed gastric emptying.
Selected research
Industry Growth & Trends
Global Diabetic Gastroparesis Treatment Industry Growth and Trends Forecast to 2032
Market perspective
Diabetic gastroparesis refers to cases of the digestive condition gastroparesis that diabetes causes.
During normal digestion, the stomach contracts to help break down food and move it into the small intestine. Gastroparesis disrupts the stomach’s contraction, which can interrupt digestion. Diabetes can cause gastroparesis due to its effects on the nervous system.
Both type 1 diabetes and type 2 diabetes can cause nerve damage. One of the nerves diabetes may damage is the vagus nerve. The vagus nerve controls the movement of food through the stomach. When the vagus nerve experiences damage, the muscles in the stomach and other parts of the digestive tract are not able to function properly. When this happens, food cannot move as quickly through the digestive system. Gastroparesis is also known as delayed gastric emptying.
Read the full market overview
According to APO Research, the global Diabetic Gastroparesis Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
Report Scope
This report provides a structured, data-driven view of the global Diabetic Gastroparesis Treatment market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Diabetic Gastroparesis Treatment market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Diabetic Gastroparesis Treatment market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Diabetic Gastroparesis Treatment.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Diabetic Gastroparesis Treatment market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Diabetic Gastroparesis Treatment Market by Company
Sumitomo
Johnson & Johnson
Sanofi
Medtronic
Pfizer
Teva
Boston Scientific
Diabetic Gastroparesis Treatment Segment by Type
Drugs
Surgical Treatment Products
Diabetic Gastroparesis Treatment Segment by Application
Hospital Pharmacies
Private Clinics
Drug Stores
E-Commerce
Diabetic Gastroparesis Treatment Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Diabetic Gastroparesis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Diabetic Gastroparesis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Diabetic Gastroparesis Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Diabetic Gastroparesis Treatment companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Drugs
- Surgical Treatment Products
Applications
- Hospital Pharmacies
- Private Clinics
- Drug Stores
- E-Commerce
Companies covered
- Sumitomo
- Johnson & Johnson
- Sanofi
- Medtronic
- Pfizer
- Teva
- Boston Scientific
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Diabetic Gastroparesis Treatment Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Diabetic Gastroparesis Treatment Market Size by Region (2021-2032)
- 1.4.1 Global Diabetic Gastroparesis Treatment Market Size by Region (2021-2026)
- 1.4.2 Global Diabetic Gastroparesis Treatment Market Size by Region (2027-2032)
- 1.5 Key Regions Diabetic Gastroparesis Treatment Market Size (2021-2032)
- 1.5.1 North America Diabetic Gastroparesis Treatment Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Diabetic Gastroparesis Treatment Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Diabetic Gastroparesis Treatment Market Size Growth Rate (2021-2032)
- 1.5.4 South America Diabetic Gastroparesis Treatment Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Diabetic Gastroparesis Treatment Market Size Growth Rate (2021-2032)
2 Diabetic Gastroparesis Treatment Market by Type
- 2.1 Type Introduction
- 2.1.1 Drugs
- 2.1.2 Surgical Treatment Products
- 2.2 Global Diabetic Gastroparesis Treatment Market Size by Type
- 2.2.1 Global Diabetic Gastroparesis Treatment Market Size Overview by Type (2021-2032)
- 2.2.2 Global Diabetic Gastroparesis Treatment Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Diabetic Gastroparesis Treatment Market Size Forecasted by Type (2027-2032)
- 2.3 Global Diabetic Gastroparesis Treatment Market Size by Regions
- 2.3.1 North America Diabetic Gastroparesis Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Diabetic Gastroparesis Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Diabetic Gastroparesis Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Diabetic Gastroparesis Treatment Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Diabetic Gastroparesis Treatment Market Size Breakdown by Type (2021-2026)
3 Diabetic Gastroparesis Treatment Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital Pharmacies
- 3.1.2 Private Clinics
- 3.1.3 Drug Stores
- 3.1.4 E-Commerce
- 3.2 Global Diabetic Gastroparesis Treatment Market Size by Application
- 3.2.1 Global Diabetic Gastroparesis Treatment Market Size Overview by Application (2021-2032)
- 3.2.2 Global Diabetic Gastroparesis Treatment Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Diabetic Gastroparesis Treatment Market Size Forecasted by Application (2027-2032)
- 3.3 Global Diabetic Gastroparesis Treatment Market Size by Regions
- 3.3.1 North America Diabetic Gastroparesis Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Diabetic Gastroparesis Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Diabetic Gastroparesis Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Diabetic Gastroparesis Treatment Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Diabetic Gastroparesis Treatment Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Diabetic Gastroparesis Treatment Industry Trends
- 4.2 Diabetic Gastroparesis Treatment Industry Drivers
- 4.3 Diabetic Gastroparesis Treatment Industry Opportunities and Challenges
- 4.4 Diabetic Gastroparesis Treatment Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Diabetic Gastroparesis Treatment Revenue (2021-2026)
- 5.2 Global Diabetic Gastroparesis Treatment Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Diabetic Gastroparesis Treatment Key Company Headquarters & Area Served
- 5.4 Global Diabetic Gastroparesis Treatment Company, Product Type & Application
- 5.5 Global Diabetic Gastroparesis Treatment Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Diabetic Gastroparesis Treatment Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Diabetic Gastroparesis Treatment Players Market Share by Revenue in 2025
- 5.6.3 2025 Diabetic Gastroparesis Treatment Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Sumitomo
- 6.1.1 Sumitomo Company Information
- 6.1.2 Sumitomo Business Overview
- 6.1.3 Sumitomo Diabetic Gastroparesis Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Sumitomo Diabetic Gastroparesis Treatment Product Portfolio
- 6.1.5 Sumitomo Recent Developments
- 6.2 Johnson & Johnson
- 6.2.1 Johnson & Johnson Company Information
- 6.2.2 Johnson & Johnson Business Overview
- 6.2.3 Johnson & Johnson Diabetic Gastroparesis Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Johnson & Johnson Diabetic Gastroparesis Treatment Product Portfolio
- 6.2.5 Johnson & Johnson Recent Developments
- 6.3 Sanofi
- 6.3.1 Sanofi Company Information
- 6.3.2 Sanofi Business Overview
- 6.3.3 Sanofi Diabetic Gastroparesis Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Sanofi Diabetic Gastroparesis Treatment Product Portfolio
- 6.3.5 Sanofi Recent Developments
- 6.4 Medtronic
- 6.4.1 Medtronic Company Information
- 6.4.2 Medtronic Business Overview
- 6.4.3 Medtronic Diabetic Gastroparesis Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Medtronic Diabetic Gastroparesis Treatment Product Portfolio
- 6.4.5 Medtronic Recent Developments
- 6.5 Pfizer
- 6.5.1 Pfizer Company Information
- 6.5.2 Pfizer Business Overview
- 6.5.3 Pfizer Diabetic Gastroparesis Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Pfizer Diabetic Gastroparesis Treatment Product Portfolio
- 6.5.5 Pfizer Recent Developments
- 6.6 Teva
- 6.6.1 Teva Company Information
- 6.6.2 Teva Business Overview
- 6.6.3 Teva Diabetic Gastroparesis Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Teva Diabetic Gastroparesis Treatment Product Portfolio
- 6.6.5 Teva Recent Developments
- 6.7 Boston Scientific
- 6.7.1 Boston Scientific Company Information
- 6.7.2 Boston Scientific Business Overview
- 6.7.3 Boston Scientific Diabetic Gastroparesis Treatment Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Boston Scientific Diabetic Gastroparesis Treatment Product Portfolio
- 6.7.5 Boston Scientific Recent Developments
7 North America
- 7.1 North America Diabetic Gastroparesis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Diabetic Gastroparesis Treatment Market Size by Country (2021-2026)
- 7.3 North America Diabetic Gastroparesis Treatment Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Diabetic Gastroparesis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Diabetic Gastroparesis Treatment Market Size by Country (2021-2026)
- 8.3 Europe Diabetic Gastroparesis Treatment Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Diabetic Gastroparesis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Diabetic Gastroparesis Treatment Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Diabetic Gastroparesis Treatment Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Diabetic Gastroparesis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Diabetic Gastroparesis Treatment Market Size by Country (2021-2026)
- 10.3 South America Diabetic Gastroparesis Treatment Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Diabetic Gastroparesis Treatment Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Diabetic Gastroparesis Treatment Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Diabetic Gastroparesis Treatment Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst